Recent content by Desmond_84

Hi guys, My God! I just had a look at the Youtube Channel I created for the 8th World Congress to upload all the videos and realised it was over 7 years ago! Time flies. I think we should definitely try and send someone to the Congress. The information we get is invaluable. I have a lot of...

Hi guys, Has there been any announcements about Phase 3 yet or are they waiting for the Phase 2 female trial to finish so they can run Phase 3 for both male and female patients combined?

I'm personally shocked not a single treatment made it to Phase 3 by 2021. The tissue engineering routes also never made it past animal studies. Sad state of affairs indeed

I'm sorry if I came across as bashing Replicel. I think DSC cells definitely would be beneficial. Our current understanding is that DSC cells are the seeds for DP cells. I think with enough regular injections over a course of 2-3 years you may be able to make DP cells immune to DHT. What...

For those not familiar with Aderans in early 2000s, they also launched their own dermal injector and made a big deal about it. At the end of the day, when Phase 2 trials ended, they shelved the injector and it was the end of that. I wouldn't put too much weight on Replicel's injector news as...

Gliamed still has a website. They've been stuck in preclinical stage since the beginning. Here's their Androgenetic Alopecia product description: To date, GliaMed has shown compelling evidence in animal models that administration of GM1485 promotes: Rapid regeneration of all components of skin following...

Further update on Hygeia pharmaceuticals topical antoandrogen HYG-440. It seems like they were purchased by RestoreGenex Pharmaceuticals during the preclinical stage in 2011. RestoreGenex then merged with Diffusion Pharmaceuticals in 2015. The new merger decided to shelve the topical...

Speaking of the pipeline. Someone just emailed me asking me about my post in 2013 on BTT. Here's the original post: OK guys. I did a lot of digging around last night and here's what I found: Hyundai Pharmaceuticals: Their R&D is useless to us. They're developing another 5-alpha reductase...

If this was the case and you could launch a stem cell therapy with a single phase trial and 13 participants, Shiseido should have launched their product in 2018, yet here we are, 4 years have passed and we are still waiting.

As far as I'm aware only 3 therapies have gone through the conditional approval process and all 3 conducted a small Phase 1 safety trial followed by a Phase 2 proof of concept. Although Phase 2 only lasts 6 - 12 months, patients need to be assessed for a good 6 months after the Phase 1 first in...

Tsuji and TissUse will take at least 5 years to come to market if they start their trials today. Neither have conducted a Proof of Concept or Phase 1 trial. You need to finish Phase 2 to commercialise

Whats crazy is this was a simple single cell therapy. What Tsuji and Lauster are proposing are infinitely more complex both in terms of tissue engineering and successful transplantation. Complexity introduces risks which will require a significant amount of tweaking and safety checks. This will...

I'm also extremely worried. Disappointment seems to be the MO in the field of cutting edge medicine.

I think at this point, we only have CB and Samumed that might actually be released for Androgenetic Alopecia in the next 3-4 years. Everything else is a 50/50 and most likely at least 5-10 years away if it does make it to market. And that's a big if. Follica has been a year away since 2012. Replicel's...

We have the trial results delayed by 18 months and Replicel has been completely shut out of the trial outcome. If you follow the pharma industry you know this is not a good sign. No interim data, no hint at trial efficacy. It all seems quite worrying.